Thursday, 25 April 2024
Sellas Life Sciences Group Inc.
NASDAQ : SLS
1.910 14 Oct 22 00:00 | Change: 0.00 | Open: 1.900 | High: 1.920 | Ask: 0.000 | Volume: 58,600 |
Change(%): 0.00 | Prev: 1.910 | Low: 1.840 | Bid: 0.000 | Avg vol: 0 |
00:03 | 18/3/18
Frisco Fastball
Among 7 analysts covering Galena Biopharma (NASDAQ:GALE), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Galena Biopharma has $6 highest and $2 lowest target.
more»
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer indications, today ...
more»
10:11 | 6/3/18
GlobeNewswire
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq:SLS) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer indications, today announced that ...
more»
10:11 | 6/3/18
GlobeNewswire
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq:SLS) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer indications, today announced that ...
more»
04:22 | 6/3/18
Street Observer
SELLAS Life Sciences Group, Inc. (SLS) stock price traded with surging change along with the volume 0.03 million shares in Friday trading session.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |